Bridging the Gap with Translational Imaging: Drug Development from Mouse to Man

Contemporary drug development is well understood to be a lengthy process. Translational research approaches, focused herein on those involving Molecular Imaging (MI), have improved to decrease time through both micro- and macro-level assessments. As a multidisciplinary field, the focus of MI is the evaluation of biological processes at the molecular, cellular, whole organ and/or system level in vivo. Improvements in imaging instrumentation and informatics over the past decade have enabled an increase in novel, translational in vivo imaging applications with comparable relative) resolution and sensitivity between preclinical and clinical imaging. Understanding the significant variances between protocol execution and data processing demands between a preclinical laboratory and the clinic is critical for the successful design of a robust development program. This webinar, part one in a two-part series, will focus on how translational molecular imaging is employed in drug development through the presentation of a broad array of case studies. The research approaches presented will show how MI bridges preclinical development efforts with clinical efforts in an effort to gain both time and cost efficiencies. All participants will have the opportunity to ask questions and discuss relevant issues.

Apr 18 2014

60 mins